These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 591830)

  • 21. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
    Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
    Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific estrogen binding in vivo in the R3230AC mammary adenocarcinoma of the rat.
    Boylan ES; Wittliff JL
    Cancer Res; 1973 Nov; 33(11):2903-8. PubMed ID: 4355983
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of oestradiol-17beta and tamoxifen on nuclear oestradiol-17beta receptors in DMBA-induced rat mammary tumours.
    Nicholson RI; Davies P; Griffiths K
    Eur J Cancer (1965); 1977 Mar; 13(3):201-8. PubMed ID: 405219
    [No Abstract]   [Full Text] [Related]  

  • 25. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biological significance of estradiol receptor binding to DNA.
    Khan S; Feldman M; Hollander VP
    Cancer Res; 1980 Apr; 40(4):1050-3. PubMed ID: 7357535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system.
    Rorke EA; Katzenellenbogen BS
    Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiestrogenic and antitumor properties of tamoxifen in laboratory animals.
    Jordan VC
    Cancer Treat Rep; 1976 Oct; 60(10):1409-19. PubMed ID: 828517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oestrogen receptor activity and intranuclear translocation in ovarian-dependent and -independent rat mammary tumours [proceedings].
    Hawkins RA; Scott KM; Freedman B
    J Endocrinol; 1978 May; 77(2):63P-64P. PubMed ID: 660071
    [No Abstract]   [Full Text] [Related]  

  • 30. An improved assay for nuclear estrogen receptor in experimental and human breast cancer.
    Garola RE; McGuire WL
    Cancer Res; 1977 Sep; 37(9):3333-7. PubMed ID: 884677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen and progesterone receptor levels in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors in each week--check points about experimental studies using DMBA-induced tumors.
    Iino Y; Izuo M; Horiuchi R
    Jpn J Exp Med; 1990 Dec; 60(6):351-4. PubMed ID: 2128946
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of estradiol, progesterone, and prolactin receptors in nitrosomethylurea-induced mammary tumors and effect of antiestrogen treatment on the development and growth of these tumors.
    Turcot-Lemay L; Kelly PA
    Cancer Res; 1980 Sep; 40(9):3232-40. PubMed ID: 6253058
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of anti-oestrogens on the specific binding in vitro of (3H)oestradiol by cytosol of rat mammary tumours and human breast carcinomata.
    Powell-Jones W; Jenner DA; Blamey RW; Davies P; Griffiths K
    Biochem J; 1975 Jul; 150(1):71-5. PubMed ID: 173302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of a mathematical model for two component receptor binding to two high affinity oestrogen binding sites in nuclei from DMBA rat mammary tumours.
    Clark ER; Mackay D; Robinson SP
    J Steroid Biochem; 1988 Apr; 29(4):375-80. PubMed ID: 3131591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The binding of tamoxifen to human mammary carcinoma cytosol.
    Sutherland RL; Murphy LC
    Eur J Cancer (1965); 1980 Sep; 16(9):1141-8. PubMed ID: 7227442
    [No Abstract]   [Full Text] [Related]  

  • 36. Equilibrium: the intracellular distribution of steroid receptors.
    Sheridan PJ; Buchanan JM; Anselmo VC; Martin PM
    Nature; 1979 Dec; 282(5739):579-82. PubMed ID: 551293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tamoxifen as an anti-tumour agent: oestrogen binding as a predictive test for tumour response.
    Jordan VC; Jaspan T
    J Endocrinol; 1976 Mar; 68(3):453-60. PubMed ID: 1255105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of tamoxifen by isolated rat hepatocytes: anti-estrogenic activity of tamoxifen N-oxide.
    Bates DJ; Foster AB; Griggs LJ; Jarman M; Leclercq G; Devleeshouwer N
    Biochem Pharmacol; 1982 Sep; 31(17):2823-7. PubMed ID: 7138577
    [No Abstract]   [Full Text] [Related]  

  • 39. Influence of antioestrogens on specific binding of [3H]oestradiol in vitro by nuclei from rat mammary tumours.
    Powell-Jones W; Davies P; Griffiths K
    J Endocrinol; 1975 Sep; 66(3):437-8. PubMed ID: 1194818
    [No Abstract]   [Full Text] [Related]  

  • 40. Improved gel-filtration method for analysis of estrogen receptor binding.
    Godefroi VC; Brooks SC
    Anal Biochem; 1973 Feb; 51(2):335-44. PubMed ID: 4349450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.